Sequoia China co-leads $188m round in Covid vaccine developer Stemirna

Sequoia China co-leads $188m round in Covid vaccine developer Stemirna

Photo: National Cancer Institute/Unsplash

03 June, 2021

Stemirna Therapeutics

Printed by Unregistered user on Tue, 29 Jul 2025 05:21:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Stemirna to raise $50m for clinical trials of COVID vaccine pipeline

Venture Capital

Sequoia Capital China files for three new funds with SEC

Read more from Greater China

HK’s Flow Capital Partners launches $125m credit fund, expands Asia focus

China’s FountainVest to buy major stake in Italy’s EuroGroup Laminations